Metropolitan Life Insurance Company (MetLife)’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,773
| Closed | -$24.9K | – | 1888 |
|
|
2024
Q1 | $24.9K | Sell |
2,773
-699
| -20% | -$6.27K | ﹤0.01% | 1752 |
|
|
2023
Q4 | $39K | Hold |
3,472
| – | – | ﹤0.01% | 1578 |
|
|
2023
Q3 | $30K | Hold |
3,472
| – | – | ﹤0.01% | 1681 |
|
|
2023
Q2 | $35.9K | Buy |
+3,472
| New | +$35.9K | ﹤0.01% | 1621 |
|
|
2023
Q1 | – | Sell |
-4,078
| Closed | -$45.8K | – | 2458 |
|
|
2022
Q4 | $45.8K | Hold |
4,078
| – | – | ﹤0.01% | 1530 |
|
|
2022
Q3 | $41.4K | Hold |
4,078
| – | – | ﹤0.01% | 1587 |
|
|
2022
Q2 | $36.9K | Hold |
4,078
| – | – | ﹤0.01% | 1686 |
|
|
2022
Q1 | $39K | Sell |
4,078
-8,223
| -67% | -$78.6K | ﹤0.01% | 1730 |
|
|
2021
Q4 | $136K | Buy |
12,301
+4,769
| +63% | +$52.7K | ﹤0.01% | 2279 |
|
|
2021
Q3 | $55.7K | Buy |
+7,532
| New | +$55.7K | ﹤0.01% | 2746 |
|
|
2021
Q2 | – | Sell |
-13,313
| Closed | -$272K | – | 2872 |
|
|
2021
Q1 | $272K | Sell |
13,313
-940
| -7% | -$19.2K | ﹤0.01% | 1803 |
|
|
2020
Q4 | $253K | Hold |
14,253
| – | – | ﹤0.01% | 1780 |
|
|
2020
Q3 | $211K | Hold |
14,253
| – | – | ﹤0.01% | 1737 |
|
|
2020
Q2 | $299K | Hold |
14,253
| – | – | 0.01% | 1545 |
|
|
2020
Q1 | $329K | Buy |
14,253
+352
| +3% | +$8.14K | 0.01% | 1305 |
|
|
2019
Q4 | $360K | Sell |
13,901
-713
| -5% | -$18.5K | 0.01% | 1530 |
|
|
2019
Q3 | $285K | Hold |
14,614
| – | – | ﹤0.01% | 1637 |
|
|
2019
Q2 | $239K | Hold |
14,614
| – | – | ﹤0.01% | 1777 |
|
|
2019
Q1 | $331K | Hold |
14,614
| – | – | 0.01% | 1562 |
|
|
2018
Q4 | $374K | Buy |
14,614
+592
| +4% | +$15.1K | 0.01% | 1398 |
|
|
2018
Q3 | $458K | Buy |
+14,022
| New | +$458K | 0.01% | 1438 |
|
|
2014
Q3 | – | Sell |
-18,407
| Closed | -$625K | – | 2725 |
|
|
2014
Q2 | $625K | Buy |
+18,407
| New | +$625K | ﹤0.01% | 1671 |
|